CMBT vs HP

CMBT presents a contradictory profile: explosive revenue growth (160% YoY) paired with a deteriorating earnings track record and poor liquidity. While the Piotroski F-Score of 6/9 indicates stable financial health, the company has missed earnings estimates in 4 consecutive quarters with a severe average surprise of -156.54%. The stock trades slightly above its Graham Number ($11.93) and significantly above its growth-based intrinsic value ($4.90), suggesting a valuation premium that is not currently supported by bottom-line performance. High leverage (Debt/Equity 2.12) and a current ratio below 1.0 create a precarious financial position despite strong operating margins.

HP presents a stark divergence between price action and fundamental performance. While the Piotroski F-Score of 5/9 indicates stable financial health and revenue growth is impressive at 50.2%, the company is suffering from a severe earnings collapse with YoY EPS growth of -121.1%. The stock is trading near its 52-week high despite negative profit margins and a prohibitively high PEG ratio of 6.81. Combined with bearish insider sentiment and a technical trend score of 10/100, the current valuation appears unsustainable.